12 results
DEFA14A
SURF
Surface Oncology, Inc.
30 Aug 23
Additional proxy soliciting materials
4:34pm
disclosures to the Proxy Statement. Nothing in this Current Report on Form 8-K shall be deemed an admission of the legal necessity or materiality under
425
SURF
Surface Oncology, Inc.
30 Aug 23
Business combination disclosure
4:32pm
necessity or materiality under applicable laws of any of the supplemental disclosures set forth herein. To the contrary, the Company and Parent specifically
8-K
SURF
Surface Oncology, Inc.
30 Aug 23
Other Events
4:31pm
disclosures to the Proxy Statement. Nothing in this Current Report on Form 8-K shall be deemed an admission of the legal necessity or materiality
DEFM14A
SURF
Surface Oncology, Inc.
26 Jul 23
Proxy related to merger
4:56pm
party with certain of its covenants, in each case, subject to the materiality standards set forth in the Merger Agreement, and the absence … materiality and material adverse effect qualifiers), the performance by the other party in all material respects of its obligations under the Merger
425
bohxp h2cz
16 Jun 23
Business combination disclosure
8:08am
8-K
z1c9vtzub02
16 Jun 23
Coherus to Acquire Surface Oncology
7:45am
8-K
EX-2.1
a4d5hlii03so2c
16 Jun 23
Coherus to Acquire Surface Oncology
7:45am
425
v1yol7
16 Jun 23
Business combination disclosure
7:09am
8-K
EX-10.1
55j7 ufurr7lq
4 Oct 21
Entry into a Material Definitive Agreement
7:05am
8-K
EX-10.1
3dfmv0
25 Nov 19
Surface Oncology Announces $25 Million Debt Financing from K2 HealthVentures
8:07am
- Prev
- 1
- Next